Respiratory viral infections within one year after pediatric lung transplant
: To characterize epidemiology and risk factors for respiratory viral infections (RVI) in pediatric lung transplant recipients within the first post‐transplant year, a retrospective multicenter study of pediatric lung transplant recipients from 1988 to 2005 was conducted at 14 centers in the United...
Saved in:
| Published in | Transplant infectious disease Vol. 11; no. 4; pp. 304 - 312 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Malden, USA
Blackwell Publishing Inc
01.08.2009
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | : To characterize epidemiology and risk factors for respiratory viral infections (RVI) in pediatric lung transplant recipients within the first post‐transplant year, a retrospective multicenter study of pediatric lung transplant recipients from 1988 to 2005 was conducted at 14 centers in the United States and Europe. Data were recorded for 1 year post transplant. Associations between RVI and continuous and categorical risk factors were assessed using Wilcoxon's rank‐sum and χ2 tests, respectively. Associations between time to RVI and risk factors or survival were assessed by multivariable Cox proportional hazards models. Of 576 subjects, 79 subjects (14%) had 101 RVI in the first year post transplant. Subjects with RVI were younger than those without RVI (median ages 9.7, 13; P<0.01). Viruses detected included adenovirus (n=25), influenza (n=9), respiratory syncytial virus (n=21), parainfluenza virus (n=19), enterovirus (n=4), and rhinovirus (n=22). In a multivariable model for time to first RVI, etiology other than cystic fibrosis (CF), younger age, and no induction therapy were independently associated with risk of RVI. Cytomegalovirus serostatus and acute rejection were not associated with RVI. RVI was independently associated with decreased 12‐month survival (hazard ratio 2.6, 95% confidence interval 1.6–4.4). RVI commonly occurs after pediatric lung transplantation with risk factors including younger age and non‐CF diagnosis. RVI is associated with decreased 1‐year survival. |
|---|---|
| AbstractList | M. Liu, S. Worley, S. Arrigain, P. Aurora, M. Ballmann, D. Boyer, C. Conrad, I. Eichler, O. Elidemir, S. Goldfarb, G.B. Mallory, P.J. Mogayzel, D. Parakininkas, G. Visner, S. Sweet, A. Faro, M. Michaels, L.A. Danziger-Isakov. Respiratory viral infections within one year after pediatric lung transplant.Transpl Infect Dis 2009: 11: 304-312. All rights reservedAbstract: To characterize epidemiology and risk factors for respiratory viral infections (RVI) in pediatric lung transplant recipients within the first post-transplant year, a retrospective multicenter study of pediatric lung transplant recipients from 1988 to 2005 was conducted at 14 centers in the United States and Europe. Data were recorded for 1 year post transplant. Associations between RVI and continuous and categorical risk factors were assessed using Wilcoxon's rank-sum and j2 tests, respectively. Associations between time to RVI and risk factors or survival were assessed by multivariable Cox proportional hazards models. Of 576 subjects, 79 subjects (14%) had 101 RVI in the first year post transplant. Subjects with RVI were younger than those without RVI (median ages 9.7, 13; P<0.01). Viruses detected included adenovirus (n=25), influenza (n=9), respiratory syncytial virus (n=21), parainfluenza virus (n=19), enterovirus (n=4), and rhinovirus (n=22). In a multivariable model for time to first RVI, etiology other than cystic fibrosis (CF), younger age, and no induction therapy were independently associated with risk of RVI. Cytomegalovirus serostatus and acute rejection were not associated with RVI. RVI was independently associated with decreased 12-month survival (hazard ratio 2.6, 95% confidence interval 1.6-4.4). RVI commonly occurs after pediatric lung transplantation with risk factors including younger age and non-CF diagnosis. RVI is associated with decreased 1-year survival. : To characterize epidemiology and risk factors for respiratory viral infections (RVI) in pediatric lung transplant recipients within the first post‐transplant year, a retrospective multicenter study of pediatric lung transplant recipients from 1988 to 2005 was conducted at 14 centers in the United States and Europe. Data were recorded for 1 year post transplant. Associations between RVI and continuous and categorical risk factors were assessed using Wilcoxon's rank‐sum and χ2 tests, respectively. Associations between time to RVI and risk factors or survival were assessed by multivariable Cox proportional hazards models. Of 576 subjects, 79 subjects (14%) had 101 RVI in the first year post transplant. Subjects with RVI were younger than those without RVI (median ages 9.7, 13; P<0.01). Viruses detected included adenovirus (n=25), influenza (n=9), respiratory syncytial virus (n=21), parainfluenza virus (n=19), enterovirus (n=4), and rhinovirus (n=22). In a multivariable model for time to first RVI, etiology other than cystic fibrosis (CF), younger age, and no induction therapy were independently associated with risk of RVI. Cytomegalovirus serostatus and acute rejection were not associated with RVI. RVI was independently associated with decreased 12‐month survival (hazard ratio 2.6, 95% confidence interval 1.6–4.4). RVI commonly occurs after pediatric lung transplantation with risk factors including younger age and non‐CF diagnosis. RVI is associated with decreased 1‐year survival. Abstract: To characterize epidemiology and risk factors for respiratory viral infections (RVI) in pediatric lung transplant recipients within the first post‐transplant year, a retrospective multicenter study of pediatric lung transplant recipients from 1988 to 2005 was conducted at 14 centers in the United States and Europe. Data were recorded for 1 year post transplant. Associations between RVI and continuous and categorical risk factors were assessed using Wilcoxon's rank‐sum and χ 2 tests, respectively. Associations between time to RVI and risk factors or survival were assessed by multivariable Cox proportional hazards models. Of 576 subjects, 79 subjects (14%) had 101 RVI in the first year post transplant. Subjects with RVI were younger than those without RVI (median ages 9.7, 13; P <0.01). Viruses detected included adenovirus ( n =25), influenza ( n =9), respiratory syncytial virus ( n =21), parainfluenza virus ( n =19), enterovirus ( n =4), and rhinovirus ( n =22). In a multivariable model for time to first RVI, etiology other than cystic fibrosis (CF), younger age, and no induction therapy were independently associated with risk of RVI. Cytomegalovirus serostatus and acute rejection were not associated with RVI. RVI was independently associated with decreased 12‐month survival (hazard ratio 2.6, 95% confidence interval 1.6–4.4). RVI commonly occurs after pediatric lung transplantation with risk factors including younger age and non‐CF diagnosis. RVI is associated with decreased 1‐year survival. To characterize epidemiology and risk factors for respiratory viral infections (RVI) in pediatric lung transplant recipients within the first post‐transplant year, a retrospective multicenter study of pediatric lung transplant recipients from 1988 to 2005 was conducted at 14 centers in the United States and Europe. Data were recorded for 1 year post transplant. Associations between RVI and continuous and categorical risk factors were assessed using Wilcoxon's rank‐sum and χ 2 tests, respectively. Associations between time to RVI and risk factors or survival were assessed by multivariable Cox proportional hazards models. Of 576 subjects, 79 subjects (14%) had 101 RVI in the first year post transplant. Subjects with RVI were younger than those without RVI (median ages 9.7, 13; P <0.01). Viruses detected included adenovirus ( n =25), influenza ( n =9), respiratory syncytial virus ( n =21), parainfluenza virus ( n =19), enterovirus ( n =4), and rhinovirus ( n =22). In a multivariable model for time to first RVI, etiology other than cystic fibrosis (CF), younger age, and no induction therapy were independently associated with risk of RVI. Cytomegalovirus serostatus and acute rejection were not associated with RVI. RVI was independently associated with decreased 12‐month survival (hazard ratio 2.6, 95% confidence interval 1.6–4.4). RVI commonly occurs after pediatric lung transplantation with risk factors including younger age and non‐CF diagnosis. RVI is associated with decreased 1‐year survival. To characterize epidemiology and risk factors for respiratory viral infections (RVI) in pediatric lung transplant recipients within the first post-transplant year, a retrospective multicenter study of pediatric lung transplant recipients from 1988 to 2005 was conducted at 14 centers in the United States and Europe. Data were recorded for 1 year post transplant. Associations between RVI and continuous and categorical risk factors were assessed using Wilcoxon's rank-sum and chi(2) tests, respectively. Associations between time to RVI and risk factors or survival were assessed by multivariable Cox proportional hazards models. Of 576 subjects, 79 subjects (14%) had 101 RVI in the first year post transplant. Subjects with RVI were younger than those without RVI (median ages 9.7, 13; P<0.01). Viruses detected included adenovirus (n=25), influenza (n=9), respiratory syncytial virus (n=21), parainfluenza virus (n=19), enterovirus (n=4), and rhinovirus (n=22). In a multivariable model for time to first RVI, etiology other than cystic fibrosis (CF), younger age, and no induction therapy were independently associated with risk of RVI. Cytomegalovirus serostatus and acute rejection were not associated with RVI. RVI was independently associated with decreased 12-month survival (hazard ratio 2.6, 95% confidence interval 1.6-4.4). RVI commonly occurs after pediatric lung transplantation with risk factors including younger age and non-CF diagnosis. RVI is associated with decreased 1-year survival. To characterize epidemiology and risk factors for respiratory viral infections (RVI) in pediatric lung transplant recipients within the first post-transplant year, a retrospective multicenter study of pediatric lung transplant recipients from 1988 to 2005 was conducted at 14 centers in the United States and Europe. Data were recorded for 1 year post transplant. Associations between RVI and continuous and categorical risk factors were assessed using Wilcoxon's rank-sum and chi(2) tests, respectively. Associations between time to RVI and risk factors or survival were assessed by multivariable Cox proportional hazards models. Of 576 subjects, 79 subjects (14%) had 101 RVI in the first year post transplant. Subjects with RVI were younger than those without RVI (median ages 9.7, 13; P<0.01). Viruses detected included adenovirus (n=25), influenza (n=9), respiratory syncytial virus (n=21), parainfluenza virus (n=19), enterovirus (n=4), and rhinovirus (n=22). In a multivariable model for time to first RVI, etiology other than cystic fibrosis (CF), younger age, and no induction therapy were independently associated with risk of RVI. Cytomegalovirus serostatus and acute rejection were not associated with RVI. RVI was independently associated with decreased 12-month survival (hazard ratio 2.6, 95% confidence interval 1.6-4.4). RVI commonly occurs after pediatric lung transplantation with risk factors including younger age and non-CF diagnosis. RVI is associated with decreased 1-year survival.To characterize epidemiology and risk factors for respiratory viral infections (RVI) in pediatric lung transplant recipients within the first post-transplant year, a retrospective multicenter study of pediatric lung transplant recipients from 1988 to 2005 was conducted at 14 centers in the United States and Europe. Data were recorded for 1 year post transplant. Associations between RVI and continuous and categorical risk factors were assessed using Wilcoxon's rank-sum and chi(2) tests, respectively. Associations between time to RVI and risk factors or survival were assessed by multivariable Cox proportional hazards models. Of 576 subjects, 79 subjects (14%) had 101 RVI in the first year post transplant. Subjects with RVI were younger than those without RVI (median ages 9.7, 13; P<0.01). Viruses detected included adenovirus (n=25), influenza (n=9), respiratory syncytial virus (n=21), parainfluenza virus (n=19), enterovirus (n=4), and rhinovirus (n=22). In a multivariable model for time to first RVI, etiology other than cystic fibrosis (CF), younger age, and no induction therapy were independently associated with risk of RVI. Cytomegalovirus serostatus and acute rejection were not associated with RVI. RVI was independently associated with decreased 12-month survival (hazard ratio 2.6, 95% confidence interval 1.6-4.4). RVI commonly occurs after pediatric lung transplantation with risk factors including younger age and non-CF diagnosis. RVI is associated with decreased 1-year survival. |
| Author | Goldfarb, S. Eichler, I. Mallory, G.B. Liu, M. Aurora, P. Worley, S. Michaels, M. Arrigain, S. Ballmann, M. Danziger-Isakov, L.A. Visner, G. Mogayzel, P.J. Boyer, D. Conrad, C. Elidemir, O. Parakininkas, D. Sweet, S. Faro, A. |
| AuthorAffiliation | 1 The Children's Hospital at Cleveland Clinic, Cleveland, Ohio, USA 4 Harvard University & Boston Children's Hospital, Boston, Massachusetts, USA 3 Hannover Medical School, Hannover, Germany 10 Medical College of Wisconsin & Children's Hospital of Wisconsin, Milwaukee, Wisconsin, USA 2 Great Ormond Street Hospital for Children & Institute of Child Health, London, UK 12 Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA 6 Medical University Vienna, Vienna, Austria 9 The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA 8 University of Pennsylvania, Philadelphia, Pennsylvania, USA 5 Stanford University, Palo Alto, California, USA 7 Baylor College of Medicine & Texas Children's Hospital, Houston, Texas, USA 11 Washington University School of Medicine & St. Louis Children's Hospital, St. Louis, Missouri, USA |
| AuthorAffiliation_xml | – name: 1 The Children's Hospital at Cleveland Clinic, Cleveland, Ohio, USA – name: 9 The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA – name: 3 Hannover Medical School, Hannover, Germany – name: 4 Harvard University & Boston Children's Hospital, Boston, Massachusetts, USA – name: 7 Baylor College of Medicine & Texas Children's Hospital, Houston, Texas, USA – name: 12 Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA – name: 8 University of Pennsylvania, Philadelphia, Pennsylvania, USA – name: 11 Washington University School of Medicine & St. Louis Children's Hospital, St. Louis, Missouri, USA – name: 10 Medical College of Wisconsin & Children's Hospital of Wisconsin, Milwaukee, Wisconsin, USA – name: 5 Stanford University, Palo Alto, California, USA – name: 2 Great Ormond Street Hospital for Children & Institute of Child Health, London, UK – name: 6 Medical University Vienna, Vienna, Austria |
| Author_xml | – sequence: 1 givenname: M. surname: Liu fullname: Liu, M. organization: The Children's Hospital at Cleveland Clinic, Cleveland, Ohio, USA – sequence: 2 givenname: S. surname: Worley fullname: Worley, S. organization: The Children's Hospital at Cleveland Clinic, Cleveland, Ohio, USA – sequence: 3 givenname: S. surname: Arrigain fullname: Arrigain, S. organization: The Children's Hospital at Cleveland Clinic, Cleveland, Ohio, USA – sequence: 4 givenname: P. surname: Aurora fullname: Aurora, P. organization: Great Ormond Street Hospital for Children & Institute of Child Health, London, UK – sequence: 5 givenname: M. surname: Ballmann fullname: Ballmann, M. organization: Hannover Medical School, Hannover, Germany – sequence: 6 givenname: D. surname: Boyer fullname: Boyer, D. organization: Harvard University & Boston Children's Hospital, Boston, Massachusetts, USA – sequence: 7 givenname: C. surname: Conrad fullname: Conrad, C. organization: Stanford University, Palo Alto, California, USA – sequence: 8 givenname: I. surname: Eichler fullname: Eichler, I. organization: Medical University Vienna, Vienna, Austria – sequence: 9 givenname: O. surname: Elidemir fullname: Elidemir, O. organization: Baylor College of Medicine & Texas Children's Hospital, Houston, Texas, USA – sequence: 10 givenname: S. surname: Goldfarb fullname: Goldfarb, S. organization: University of Pennsylvania, Philadelphia, Pennsylvania, USA – sequence: 11 givenname: G.B. surname: Mallory fullname: Mallory, G.B. organization: Baylor College of Medicine & Texas Children's Hospital, Houston, Texas, USA – sequence: 12 givenname: P.J. surname: Mogayzel fullname: Mogayzel, P.J. organization: The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA – sequence: 13 givenname: D. surname: Parakininkas fullname: Parakininkas, D. organization: Medical College of Wisconsin & Children's Hospital of Wisconsin, Milwaukee, Wisconsin, USA – sequence: 14 givenname: G. surname: Visner fullname: Visner, G. organization: Harvard University & Boston Children's Hospital, Boston, Massachusetts, USA – sequence: 15 givenname: S. surname: Sweet fullname: Sweet, S. organization: Washington University School of Medicine & St. Louis Children's Hospital, St. Louis, Missouri, USA – sequence: 16 givenname: A. surname: Faro fullname: Faro, A. organization: Washington University School of Medicine & St. Louis Children's Hospital, St. Louis, Missouri, USA – sequence: 17 givenname: M. surname: Michaels fullname: Michaels, M. organization: Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA – sequence: 18 givenname: L.A. surname: Danziger-Isakov fullname: Danziger-Isakov, L.A. organization: The Children's Hospital at Cleveland Clinic, Cleveland, Ohio, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19422670$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNUUtv1DAQtlARffEXkE_cEiZ2HMcSQkJLX7ACVK3E0XIcp_WSdYLtbXf_PU63bOFEffFI8z1m5jtGB25wBiFcQF6k926ZF1SIjEJFcgIgcgAqeL55gY72jYOHus4I4fQQHYewBCi4KMUrdFiIkpCKwxGaX5swWq_i4Lf4LhU9tq4zOtrBBXxv4611OJnjrVEeqy4aj0fTWhW91bhfuxscvXJh7JWLp-hlp_pgXj_-J2hxfraYXWbzbxdXs4_zTLMSeNayljWcq9LUhoDQhIkGlGGtakulipKXumxB06ZroGx0x2rK6oJxXjXAoaAn6MNOdlw3K9Nq49IIvRy9XSm_lYOy8t-Os7fyZriTvKhEXUESePso4IdfaxOiXNmgTZ92MMM6yIonM1KR_wIJJEFGRQK--Xuk_Sx_Dp0A9Q6g_RCCN90TBOSUqVzKKTo5RSenTOVDpnLztO6eqm1UU0BpOds_R-D9TuDe9mb7bGO5uPqUikTPdnQbotns6cr_TIeinMkfXy_k7PuX6jMXC3lJfwPgWsuw |
| CitedBy_id | crossref_primary_10_1016_j_ccm_2017_07_012 crossref_primary_10_1111_ajt_12112 crossref_primary_10_1097_MOT_0000000000000633 crossref_primary_10_1128_CMR_00077_12 crossref_primary_10_1097_QCO_0b013e3283480440 crossref_primary_10_1111_ajt_15505 crossref_primary_10_1093_jpids_piad094 crossref_primary_10_1111_j_1399_3046_2012_01744_x crossref_primary_10_1097_MOT_0000000000000630 crossref_primary_10_5863_1551_6776_16_2_77 crossref_primary_10_1016_j_ppedcard_2009_09_008 crossref_primary_10_1111_ctr_13545 crossref_primary_10_1016_j_pcl_2010_01_017 crossref_primary_10_1111_j_1600_6143_2011_03490_x crossref_primary_10_1111_tid_13422 crossref_primary_10_1016_j_semnephrol_2016_05_018 crossref_primary_10_1111_j_1399_3046_2011_01629_x crossref_primary_10_1128_CMR_00116_13 crossref_primary_10_1111_j_1399_3062_2009_00425_x crossref_primary_10_1002_ppul_26812 crossref_primary_10_1007_s11908_012_0294_0 crossref_primary_10_1097_MOT_0000000000000224 crossref_primary_10_1093_ndt_gft036 crossref_primary_10_1016_j_idc_2021_11_004 crossref_primary_10_1097_MOT_0000000000000663 crossref_primary_10_1016_S2213_2600_13_70162_0 crossref_primary_10_1097_TP_0000000000002191 crossref_primary_10_1111_petr_12765 crossref_primary_10_1002_jgm_1638 crossref_primary_10_1111_petr_12093 crossref_primary_10_1007_s40121_017_0160_3 crossref_primary_10_1111_ctr_13527 crossref_primary_10_1093_jpids_piy024 crossref_primary_10_1016_j_jaci_2012_05_024 crossref_primary_10_1128_microbiolspec_DMIH2_0006_2015 crossref_primary_10_1111_j_1399_3046_2010_01296_x crossref_primary_10_1007_s11908_015_0511_8 crossref_primary_10_1097_TP_0b013e318271d7f0 crossref_primary_10_1111_j_1399_3062_2010_00509_x crossref_primary_10_1007_s11908_014_0416_y crossref_primary_10_1055_s_0041_1729172 crossref_primary_10_1097_MPH_0000000000002525 crossref_primary_10_1586_17476348_2016_1168298 crossref_primary_10_1128_CMR_00042_19 crossref_primary_10_1111_petr_12069 crossref_primary_10_1111_petr_12022 crossref_primary_10_3389_fimmu_2019_02861 crossref_primary_10_1097_MOT_0b013e328336b8f9 crossref_primary_10_1097_QCO_0000000000000558 crossref_primary_10_1111_tid_12167 crossref_primary_10_1097_TP_0b013e31829df29d |
| Cites_doi | 10.1097/01.TP.0000069234.04901.A3 10.1111/j.1600-6143.2005.00971.x 10.1016/j.healun.2007.11.575 10.1164/rccm.200711-1657OC 10.1016/j.healun.2007.05.020 10.1097/00007890-199402150-00018 10.1016/j.athoracsur.2006.03.120 10.1016/S0022-5223(95)70419-1 10.1097/00007890-200204150-00010 10.1164/rccm.200604-489OC 10.1128/JVI.02392-08 10.1378/chest.112.4.924 10.1016/j.healun.2005.06.027 10.1016/S0022-5223(98)70168-0 10.1002/jmv.20555 10.1001/archinte.1993.00410170090009 10.1016/j.healun.2007.06.009 10.1128/JCM.01621-06 10.1378/chest.101.4.1056 10.1183/09031936.06.00105505 10.1164/rccm.200310-1359OC 10.1034/j.1600-6143.2002.20315.x |
| ContentType | Journal Article |
| Copyright | 2009 John Wiley & Sons A/S |
| Copyright_xml | – notice: 2009 John Wiley & Sons A/S |
| DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7U9 H94 7X8 5PM |
| DOI | 10.1111/j.1399-3062.2009.00397.x |
| DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Virology and AIDS Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Virology and AIDS Abstracts MEDLINE - Academic |
| DatabaseTitleList | AIDS and Cancer Research Abstracts CrossRef MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | Liu et al |
| EISSN | 1399-3062 |
| EndPage | 312 |
| ExternalDocumentID | PMC7169860 19422670 10_1111_j_1399_3062_2009_00397_x TID397 ark_67375_WNG_CPK6J79T_H |
| Genre | article Multicenter Study Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NCRR NIH HHS grantid: K23 RR022956 |
| GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1OC 29Q 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADMGS ADOZA ADXAS ADZCM AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RX1 SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 YFH YUY ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACUHS ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7U9 H94 7X8 5PM |
| ID | FETCH-LOGICAL-c5407-d5d5b77a4e8e209c259b0ae5dad4aa1474c4d0c3bfb04bcf5835815776b07013 |
| IEDL.DBID | DR2 |
| ISSN | 1398-2273 1399-3062 |
| IngestDate | Thu Aug 21 14:11:30 EDT 2025 Fri Jul 11 11:33:27 EDT 2025 Fri Jul 11 15:20:00 EDT 2025 Mon Jul 21 06:07:28 EDT 2025 Thu Apr 24 23:09:03 EDT 2025 Tue Jul 01 02:32:53 EDT 2025 Wed Jan 22 17:05:13 EST 2025 Wed Oct 30 09:45:41 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5407-d5d5b77a4e8e209c259b0ae5dad4aa1474c4d0c3bfb04bcf5835815776b07013 |
| Notes | ark:/67375/WNG-CPK6J79T-H ArticleID:TID397 istex:116889C917058A6AA8818B8E503BB8529F07EE4B ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7169860 |
| PMID | 19422670 |
| PQID | 20698539 |
| PQPubID | 23462 |
| PageCount | 9 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7169860 proquest_miscellaneous_67577262 proquest_miscellaneous_20698539 pubmed_primary_19422670 crossref_primary_10_1111_j_1399_3062_2009_00397_x crossref_citationtrail_10_1111_j_1399_3062_2009_00397_x wiley_primary_10_1111_j_1399_3062_2009_00397_x_TID397 istex_primary_ark_67375_WNG_CPK6J79T_H |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | August 2009 |
| PublicationDateYYYYMMDD | 2009-08-01 |
| PublicationDate_xml | – month: 08 year: 2009 text: August 2009 |
| PublicationDecade | 2000 |
| PublicationPlace | Malden, USA |
| PublicationPlace_xml | – name: Malden, USA – name: Denmark |
| PublicationTitle | Transplant infectious disease |
| PublicationTitleAlternate | Transpl Infect Dis |
| PublicationYear | 2009 |
| Publisher | Blackwell Publishing Inc |
| Publisher_xml | – name: Blackwell Publishing Inc |
| References | Vilchez R, McCurry K, Dauber J, et al. Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients. Transplantation 2002; 73 (7): 1075-1078. Larcher C, Geltner C, Fischer H, Nachbaur D, Muller LC, Huemer HP. Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. J Heart Lung Transplant 2005; 24 (11): 1891-1901. Garnett CT, Talekar G, Mahr JA, et al. Latent species C adenoviruses in human tonsil tissues. J Virol 2009; 83 (6): 2417-2428. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996; 15 (1 Part 1): 1-15. Doan ML, Mallory GB, Kaplan SL, et al. Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. J Heart Lung Transplant 2007; 26 (9): 883-889. Bridges ND, Spray TL, Collins MH, Bowles NE, Towbin JA. Adenovirus infection in the lung results in graft failure after lung transplantation. J Thorac Cardiovasc Surg 1998; 116 (4): 617-623. Hopkins P, McNeil K, Kermeen F, et al. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus. Am J Respir Crit Care Med 2008; 178 (8): 876-881. Dare R, Sanghavi S, Bullotta A, et al. Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis. J Clin Microbiol 2007; 45 (2): 548-552. Ison MG, Sharma A, Shepard JA, Wain JC, Ginns LC. Outcome of influenza infection managed with oseltamivir in lung transplant recipients. J Heart Lung Transplant 2008; 27 (3): 282-288. Winter JB, Gouw AS, Groen M, Wildevuur C, Prop J. Respiratory viral infections aggravate airway damage caused by chronic rejection in rat lung allografts. Transplantation 1994; 57 (3): 418-422. Blanchard SS, Gerrek M, Siegel C, Czinn SJ. Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: case report and discussion regarding need of routine prophylaxis. Pediatr Transplant 2006; 10 (7): 826-829. Kumar D, Erdman D, Keshavjee S, et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2005; 5 (8): 2031-2036. Vilchez RA, Dauber J, Kusne S. Infectious etiology of bronchiolitis obliterans: the respiratory viruses connection - myth or reality? Am J Transplant 2003; 3 (3): 245-249. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993; 12 (5): 713-716. Glanville AR, Scott AI, Morton JM, et al. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation. J Heart Lung Transplant 2005; 24 (12): 2114-2119. Kanj SS, Tapson V, Davis RD, Madden J, Browning I. Infections in patients with cystic fibrosis following lung transplantation. Chest 1997; 112 (4): 924-930. Milstone AP, Brumble LM, Barnes J, et al. A single-season prospective study of respiratory viral infections in lung transplant recipients. Eur Respir J 2006; 28 (1): 131-137. Bando K, Paradis IL, Komatsu K, et al. Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation. J Thorac Cardiovasc Surg 1995; 109 (1): 49-57; discussion 57-49. Waltz DA, Boucek MM, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: ninth official pediatric lung and heart-lung transplantation report-2006. J Heart Lung Transplant 2006; 25 (8): 904-911. Maurer JR, Tullis DE, Grossman RF, Vellend H, Winton TL, Patterson GA. Infectious complications following isolated lung transplantation. Chest 1992; 101 (4): 1056-1059. Gerna G, Vitulo P, Rovida F, et al. Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients. J Med Virol 2006; 78 (3): 408-416. Berry GJ, Brunt EM, Chamberlain D, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The international society for heart transplantation. J Heart Transplant 1990; 9 (6): 593-601. Raza K, Ismailjee SB, Crespo M, et al. Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin. J Heart Lung Transplant 2007; 26 (8): 862-864. Kramer MR, Marshall SE, Starnes VA, Gamberg P, Amitai Z, Theodore J. Infectious complications in heart-lung transplantation. Analysis of 200 episodes. Arch Intern Med 1993; 153 (17): 2010-2016. Vilchez RA, McCurry K, Dauber J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2 (3): 287-291. Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNA aemia dynamics after lung transplantation. Transplantation 2003; 75 (12): 2064-2068. Khalifah AP, Hachem RR, Chakinala MM, et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004; 170 (2): 181-187. Garantziotis S, Howell DN, McAdams HP, Davis RD, Henshaw NG, Palmer SM. Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome. Chest 2001; 119 (4): 1277-1280. Trulock EP, Christie JD, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report. J Heart Lung Transplant 2007; 26 (8): 782-795. Kuo E, Bharat A, Goers T, et al. Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation. Ann Thorac Surg 2006; 82 (3): 1043-1050. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21 (3): 297-310. Kaiser L, Aubert JD, Pache JC, et al. Chronic rhinoviral infection in lung transplant recipients. Am J Respir Crit Care Med 2006; 174 (12): 1392-1399. 2006; 78 2009; 83 2006; 10 2002; 73 1992; 101 1997; 112 2006; 174 2002; 2 1998; 116 1996; 15 2003; 75 2005; 24 2006; 82 1993; 12 2004; 170 2006; 28 2006; 25 2002; 21 2008; 27 1995; 109 2005; 5 2003; 3 1994; 57 2008; 178 2001; 119 1990; 9 2007; 45 1993; 153 2007; 26 Blanchard SS (e_1_2_6_29_2) 2006; 10 Doan ML (e_1_2_6_31_2) 2007; 26 e_1_2_6_30_2 Yousem SA (e_1_2_6_20_2) 1996; 15 Waltz DA (e_1_2_6_2_2) 2006; 25 Winter JB (e_1_2_6_18_2) 1994; 57 Kuo E (e_1_2_6_19_2) 2006; 82 e_1_2_6_13_2 e_1_2_6_10_2 e_1_2_6_33_2 e_1_2_6_11_2 Kaiser L (e_1_2_6_28_2) 2006; 174 e_1_2_6_32_2 e_1_2_6_15_2 Berry GJ (e_1_2_6_21_2) 1990; 9 Larcher C (e_1_2_6_25_2) 2005; 24 Vilchez R (e_1_2_6_16_2) 2002; 73 Estenne M (e_1_2_6_24_2) 2002; 21 Vilchez RA (e_1_2_6_12_2) 2003; 3 e_1_2_6_8_2 Kramer MR (e_1_2_6_4_2) 1993; 153 e_1_2_6_7_2 Trulock EP (e_1_2_6_22_2) 2007; 26 e_1_2_6_9_2 e_1_2_6_3_2 Maurer JR (e_1_2_6_5_2) 1992; 101 e_1_2_6_6_2 Bando K (e_1_2_6_17_2) 1995; 109 Cooper JD (e_1_2_6_23_2) 1993; 12 e_1_2_6_27_2 Garantziotis S (e_1_2_6_14_2) 2001; 119 e_1_2_6_26_2 |
| References_xml | – reference: Vilchez R, McCurry K, Dauber J, et al. Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients. Transplantation 2002; 73 (7): 1075-1078. – reference: Waltz DA, Boucek MM, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: ninth official pediatric lung and heart-lung transplantation report-2006. J Heart Lung Transplant 2006; 25 (8): 904-911. – reference: Hopkins P, McNeil K, Kermeen F, et al. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus. Am J Respir Crit Care Med 2008; 178 (8): 876-881. – reference: Gerna G, Vitulo P, Rovida F, et al. Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients. J Med Virol 2006; 78 (3): 408-416. – reference: Bridges ND, Spray TL, Collins MH, Bowles NE, Towbin JA. Adenovirus infection in the lung results in graft failure after lung transplantation. J Thorac Cardiovasc Surg 1998; 116 (4): 617-623. – reference: Kanj SS, Tapson V, Davis RD, Madden J, Browning I. Infections in patients with cystic fibrosis following lung transplantation. Chest 1997; 112 (4): 924-930. – reference: Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNA aemia dynamics after lung transplantation. Transplantation 2003; 75 (12): 2064-2068. – reference: Dare R, Sanghavi S, Bullotta A, et al. Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis. J Clin Microbiol 2007; 45 (2): 548-552. – reference: Glanville AR, Scott AI, Morton JM, et al. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation. J Heart Lung Transplant 2005; 24 (12): 2114-2119. – reference: Raza K, Ismailjee SB, Crespo M, et al. Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin. J Heart Lung Transplant 2007; 26 (8): 862-864. – reference: Vilchez RA, Dauber J, Kusne S. Infectious etiology of bronchiolitis obliterans: the respiratory viruses connection - myth or reality? Am J Transplant 2003; 3 (3): 245-249. – reference: Vilchez RA, McCurry K, Dauber J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2 (3): 287-291. – reference: Bando K, Paradis IL, Komatsu K, et al. Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation. J Thorac Cardiovasc Surg 1995; 109 (1): 49-57; discussion 57-49. – reference: Kuo E, Bharat A, Goers T, et al. Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation. Ann Thorac Surg 2006; 82 (3): 1043-1050. – reference: Kramer MR, Marshall SE, Starnes VA, Gamberg P, Amitai Z, Theodore J. Infectious complications in heart-lung transplantation. Analysis of 200 episodes. Arch Intern Med 1993; 153 (17): 2010-2016. – reference: Berry GJ, Brunt EM, Chamberlain D, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The international society for heart transplantation. J Heart Transplant 1990; 9 (6): 593-601. – reference: Trulock EP, Christie JD, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report. J Heart Lung Transplant 2007; 26 (8): 782-795. – reference: Blanchard SS, Gerrek M, Siegel C, Czinn SJ. Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: case report and discussion regarding need of routine prophylaxis. Pediatr Transplant 2006; 10 (7): 826-829. – reference: Kaiser L, Aubert JD, Pache JC, et al. Chronic rhinoviral infection in lung transplant recipients. Am J Respir Crit Care Med 2006; 174 (12): 1392-1399. – reference: Winter JB, Gouw AS, Groen M, Wildevuur C, Prop J. Respiratory viral infections aggravate airway damage caused by chronic rejection in rat lung allografts. Transplantation 1994; 57 (3): 418-422. – reference: Garnett CT, Talekar G, Mahr JA, et al. Latent species C adenoviruses in human tonsil tissues. J Virol 2009; 83 (6): 2417-2428. – reference: Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21 (3): 297-310. – reference: Larcher C, Geltner C, Fischer H, Nachbaur D, Muller LC, Huemer HP. Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. J Heart Lung Transplant 2005; 24 (11): 1891-1901. – reference: Garantziotis S, Howell DN, McAdams HP, Davis RD, Henshaw NG, Palmer SM. Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome. Chest 2001; 119 (4): 1277-1280. – reference: Milstone AP, Brumble LM, Barnes J, et al. A single-season prospective study of respiratory viral infections in lung transplant recipients. Eur Respir J 2006; 28 (1): 131-137. – reference: Kumar D, Erdman D, Keshavjee S, et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2005; 5 (8): 2031-2036. – reference: Ison MG, Sharma A, Shepard JA, Wain JC, Ginns LC. Outcome of influenza infection managed with oseltamivir in lung transplant recipients. J Heart Lung Transplant 2008; 27 (3): 282-288. – reference: Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993; 12 (5): 713-716. – reference: Khalifah AP, Hachem RR, Chakinala MM, et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004; 170 (2): 181-187. – reference: Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996; 15 (1 Part 1): 1-15. – reference: Maurer JR, Tullis DE, Grossman RF, Vellend H, Winton TL, Patterson GA. Infectious complications following isolated lung transplantation. Chest 1992; 101 (4): 1056-1059. – reference: Doan ML, Mallory GB, Kaplan SL, et al. Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. J Heart Lung Transplant 2007; 26 (9): 883-889. – volume: 109 start-page: 49 issue: (1) year: 1995 end-page: 57 article-title: Analysis of time‐dependent risks for infection, rejection, and death after pulmonary transplantation publication-title: J Thorac Cardiovasc Surg – volume: 153 start-page: 2010 issue: (17) year: 1993 end-page: 2016 article-title: Infectious complications in heart–lung transplantation. Analysis of 200 episodes publication-title: Arch Intern Med – volume: 28 start-page: 131 issue: (1) year: 2006 end-page: 137 article-title: A single‐season prospective study of respiratory viral infections in lung transplant recipients publication-title: Eur Respir J – volume: 57 start-page: 418 issue: (3) year: 1994 end-page: 422 article-title: Respiratory viral infections aggravate airway damage caused by chronic rejection in rat lung allografts publication-title: Transplantation – volume: 119 start-page: 1277 issue: (4) year: 2001 end-page: 1280 article-title: Influenza pneumonia in lung transplant recipients publication-title: clinical features and association with bronchiolitis obliterans syndrome – volume: 101 start-page: 1056 issue: (4) year: 1992 end-page: 1059 article-title: Infectious complications following isolated lung transplantation publication-title: Chest – volume: 10 start-page: 826 issue: (7) year: 2006 end-page: 829 article-title: Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation publication-title: case report and discussion regarding need of routine prophylaxis – volume: 24 start-page: 1891 issue: (11) year: 2005 end-page: 1901 article-title: Human metapneumovirus infection in lung transplant recipients publication-title: clinical presentation and epidemiology – volume: 21 start-page: 297 issue: (3) year: 2002 end-page: 310 article-title: Bronchiolitis obliterans syndrome 2001 publication-title: an update of the diagnostic criteria – volume: 9 start-page: 593 issue: (6) year: 1990 end-page: 601 article-title: A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection publication-title: Lung Rejection Study Group. The international society for heart transplantation – volume: 3 start-page: 245 issue: (3) year: 2003 end-page: 249 article-title: Infectious etiology of bronchiolitis obliterans publication-title: the respiratory viruses connection – myth or reality? – volume: 5 start-page: 2031 issue: (8) year: 2005 end-page: 2036 article-title: Clinical impact of community‐acquired respiratory viruses on bronchiolitis obliterans after lung transplant publication-title: Am J Transplant – volume: 24 start-page: 2114 issue: (12) year: 2005 end-page: 2119 article-title: Intravenous ribavirin is a safe and cost‐effective treatment for respiratory syncytial virus infection after lung transplantation publication-title: J Heart Lung Transplant – volume: 27 start-page: 282 issue: (3) year: 2008 end-page: 288 article-title: Outcome of influenza infection managed with oseltamivir in lung transplant recipients publication-title: J Heart Lung Transplant – volume: 12 start-page: 713 issue: (5) year: 1993 end-page: 716 article-title: A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation publication-title: J Heart Lung Transplant – volume: 178 start-page: 876 issue: (8) year: 2008 end-page: 881 article-title: Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus publication-title: Am J Respir Crit Care Med – volume: 26 start-page: 782 issue: (8) year: 2007 end-page: 795 article-title: Registry of the International Society for Heart and Lung Transplantation publication-title: twenty-fourth official adult lung and heart–lung transplantation report – volume: 2 start-page: 287 issue: (3) year: 2002 end-page: 291 article-title: Influenza virus infection in adult solid organ transplant recipients publication-title: Am J Transplant – volume: 78 start-page: 408 issue: (3) year: 2006 end-page: 416 article-title: Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients publication-title: J Med Virol – volume: 26 start-page: 862 issue: (8) year: 2007 end-page: 864 article-title: Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin publication-title: J Heart Lung Transplant – volume: 83 start-page: 2417 issue: 6 year: 2009 end-page: 2428 article-title: Latent species C adenoviruses in human tonsil tissues publication-title: J Virol – volume: 25 start-page: 904 issue: (8) year: 2006 end-page: 911 article-title: Registry of the International Society for Heart and Lung Transplantation publication-title: ninth official pediatric lung and heart–lung transplantation report–2006 – volume: 45 start-page: 548 issue: (2) year: 2007 end-page: 552 article-title: Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis publication-title: J Clin Microbiol – volume: 170 start-page: 181 issue: (2) year: 2004 end-page: 187 article-title: Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death publication-title: Am J Respir Crit Care Med – volume: 73 start-page: 1075 issue: (7) year: 2002 end-page: 1078 article-title: Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients publication-title: Transplantation – volume: 82 start-page: 1043 issue: (3) year: 2006 end-page: 1050 article-title: Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation publication-title: Ann Thorac Surg – volume: 15 start-page: 1 issue: (1 Part 1) year: 1996 end-page: 15 article-title: Revision of the 1990 working formulation for the classification of pulmonary allograft rejection publication-title: Lung Rejection Study Group – volume: 174 start-page: 1392 issue: (12) year: 2006 end-page: 1399 article-title: Chronic rhinoviral infection in lung transplant recipients publication-title: Am J Respir Crit Care Med – volume: 112 start-page: 924 issue: (4) year: 1997 end-page: 930 article-title: Infections in patients with cystic fibrosis following lung transplantation publication-title: Chest – volume: 116 start-page: 617 issue: (4) year: 1998 end-page: 623 article-title: Adenovirus infection in the lung results in graft failure after lung transplantation publication-title: J Thorac Cardiovasc Surg – volume: 75 start-page: 2064 issue: (12) year: 2003 end-page: 2068 article-title: Bronchiolitis obliterans syndrome and early human cytomegalovirus DNA aemia dynamics after lung transplantation publication-title: Transplantation – volume: 26 start-page: 883 issue: (9) year: 2007 end-page: 889 article-title: Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients publication-title: J Heart Lung Transplant – ident: e_1_2_6_15_2 doi: 10.1097/01.TP.0000069234.04901.A3 – volume: 26 start-page: 782 issue: 8 year: 2007 ident: e_1_2_6_22_2 article-title: Registry of the International Society for Heart and Lung Transplantation publication-title: twenty-fourth official adult lung and heart–lung transplantation report – volume: 21 start-page: 297 issue: 3 year: 2002 ident: e_1_2_6_24_2 article-title: Bronchiolitis obliterans syndrome 2001 publication-title: an update of the diagnostic criteria – ident: e_1_2_6_10_2 doi: 10.1111/j.1600-6143.2005.00971.x – ident: e_1_2_6_30_2 doi: 10.1016/j.healun.2007.11.575 – ident: e_1_2_6_7_2 doi: 10.1164/rccm.200711-1657OC – ident: e_1_2_6_33_2 doi: 10.1016/j.healun.2007.05.020 – volume: 57 start-page: 418 issue: 3 year: 1994 ident: e_1_2_6_18_2 article-title: Respiratory viral infections aggravate airway damage caused by chronic rejection in rat lung allografts publication-title: Transplantation doi: 10.1097/00007890-199402150-00018 – volume: 82 start-page: 1043 issue: 3 year: 2006 ident: e_1_2_6_19_2 article-title: Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2006.03.120 – volume: 3 start-page: 245 issue: 3 year: 2003 ident: e_1_2_6_12_2 article-title: Infectious etiology of bronchiolitis obliterans publication-title: the respiratory viruses connection – myth or reality? – volume: 12 start-page: 713 issue: 5 year: 1993 ident: e_1_2_6_23_2 article-title: A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation publication-title: J Heart Lung Transplant – volume: 109 start-page: 49 issue: 1 year: 1995 ident: e_1_2_6_17_2 article-title: Analysis of time‐dependent risks for infection, rejection, and death after pulmonary transplantation publication-title: J Thorac Cardiovasc Surg doi: 10.1016/S0022-5223(95)70419-1 – volume: 73 start-page: 1075 issue: 7 year: 2002 ident: e_1_2_6_16_2 article-title: Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients publication-title: Transplantation doi: 10.1097/00007890-200204150-00010 – volume: 174 start-page: 1392 issue: 12 year: 2006 ident: e_1_2_6_28_2 article-title: Chronic rhinoviral infection in lung transplant recipients publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200604-489OC – volume: 24 start-page: 1891 issue: 11 year: 2005 ident: e_1_2_6_25_2 article-title: Human metapneumovirus infection in lung transplant recipients publication-title: clinical presentation and epidemiology – volume: 10 start-page: 826 issue: 7 year: 2006 ident: e_1_2_6_29_2 article-title: Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation publication-title: case report and discussion regarding need of routine prophylaxis – volume: 119 start-page: 1277 issue: 4 year: 2001 ident: e_1_2_6_14_2 article-title: Influenza pneumonia in lung transplant recipients publication-title: clinical features and association with bronchiolitis obliterans syndrome – ident: e_1_2_6_27_2 doi: 10.1128/JVI.02392-08 – volume: 9 start-page: 593 issue: 6 year: 1990 ident: e_1_2_6_21_2 article-title: A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection publication-title: Lung Rejection Study Group. The international society for heart transplantation – volume: 25 start-page: 904 issue: 8 year: 2006 ident: e_1_2_6_2_2 article-title: Registry of the International Society for Heart and Lung Transplantation publication-title: ninth official pediatric lung and heart–lung transplantation report–2006 – ident: e_1_2_6_3_2 doi: 10.1378/chest.112.4.924 – volume: 15 start-page: 1 issue: 1 year: 1996 ident: e_1_2_6_20_2 article-title: Revision of the 1990 working formulation for the classification of pulmonary allograft rejection publication-title: Lung Rejection Study Group – ident: e_1_2_6_32_2 doi: 10.1016/j.healun.2005.06.027 – ident: e_1_2_6_8_2 doi: 10.1016/S0022-5223(98)70168-0 – ident: e_1_2_6_11_2 doi: 10.1002/jmv.20555 – volume: 153 start-page: 2010 issue: 17 year: 1993 ident: e_1_2_6_4_2 article-title: Infectious complications in heart–lung transplantation. Analysis of 200 episodes publication-title: Arch Intern Med doi: 10.1001/archinte.1993.00410170090009 – volume: 26 start-page: 883 issue: 9 year: 2007 ident: e_1_2_6_31_2 article-title: Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients publication-title: J Heart Lung Transplant doi: 10.1016/j.healun.2007.06.009 – ident: e_1_2_6_26_2 doi: 10.1128/JCM.01621-06 – volume: 101 start-page: 1056 issue: 4 year: 1992 ident: e_1_2_6_5_2 article-title: Infectious complications following isolated lung transplantation publication-title: Chest doi: 10.1378/chest.101.4.1056 – ident: e_1_2_6_6_2 doi: 10.1183/09031936.06.00105505 – ident: e_1_2_6_9_2 doi: 10.1164/rccm.200310-1359OC – ident: e_1_2_6_13_2 doi: 10.1034/j.1600-6143.2002.20315.x |
| SSID | ssj0017949 |
| Score | 2.1441073 |
| Snippet | : To characterize epidemiology and risk factors for respiratory viral infections (RVI) in pediatric lung transplant recipients within the first post‐transplant... To characterize epidemiology and risk factors for respiratory viral infections (RVI) in pediatric lung transplant recipients within the first post‐transplant... To characterize epidemiology and risk factors for respiratory viral infections (RVI) in pediatric lung transplant recipients within the first post-transplant... M. Liu, S. Worley, S. Arrigain, P. Aurora, M. Ballmann, D. Boyer, C. Conrad, I. Eichler, O. Elidemir, S. Goldfarb, G.B. Mallory, P.J. Mogayzel, D.... Abstract: To characterize epidemiology and risk factors for respiratory viral infections (RVI) in pediatric lung transplant recipients within the first... |
| SourceID | pubmedcentral proquest pubmed crossref wiley istex |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 304 |
| SubjectTerms | Adenovirus Adenoviruses, Human - isolation & purification Adolescent Adult Child Child, Preschool Cytomegalovirus Enterovirus Enterovirus - isolation & purification Female Humans Infant Infant, Newborn lung transplantation Lung Transplantation - adverse effects Male Original Orthomyxoviridae - isolation & purification Parainfluenza virus pediatric Respiratory syncytial virus Respiratory Syncytial Viruses - isolation & purification Respiratory Tract Infections - diagnosis Respiratory Tract Infections - epidemiology Respiratory Tract Infections - mortality Respiratory Tract Infections - virology respiratory virus infection Respirovirus - isolation & purification Rhinovirus Rhinovirus - isolation & purification Risk Factors Seasons Survival Rate Virus Cultivation Virus Diseases - diagnosis Virus Diseases - epidemiology Virus Diseases - mortality Virus Diseases - virology Young Adult |
| Title | Respiratory viral infections within one year after pediatric lung transplant |
| URI | https://api.istex.fr/ark:/67375/WNG-CPK6J79T-H/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1399-3062.2009.00397.x https://www.ncbi.nlm.nih.gov/pubmed/19422670 https://www.proquest.com/docview/20698539 https://www.proquest.com/docview/67577262 https://pubmed.ncbi.nlm.nih.gov/PMC7169860 |
| Volume | 11 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYQXLjQovJYaIsPqLesnMSO18eKFrYUULUKgpvlR1ZFGwXE7kqUX8-MswmkpdKq6i1SMlY8nvHMxF--IeSQOzmOE-8jiCY8gnjsI8uViYSMhYFyIGUOC8Xzi2x4yU-vxfUC_4T_wtT8EO0HN_SMsF-jgxs77To5BNcIUt6koZ2E2NrHfBKhW5gfjVomKTQ7FWovBYYBIbsL6nl1oE6kWkOlP7yWhv6JpnyZ5YYwdfyGTJoJ1uiUSX8-s333-Bv34__RwFuyschm6efa_DbJSlG9I2ej5-N7ihjikjaQr2pK8cPvTUVvq4L-Ai-joUk5vWs6htASdh86C5TrJaz6FsmPv-ZHw2jRtCFyyOUXeeGFldLwYlAkTDkorywzhfDGc2NiLrnjnrnUji3j1o3FABnYhJSZhd0nTrfJagWvsEsosyrNGDfCessLlliJREAmGUvvB17JHpHN-mi3IDTHvhqlflHYgII0KgjbbSodFKQfeiRuJe9qUo8lZD4FE2gFzP0EQXFS6KuLE33043t2KlWuhz1y0NiIBlfF8xdTFbfzKQyXKciO1N-fgOoNqp0s6ZGd2qaeX0_hL8-SwaQ71tY-gDTh3TvVzc9AF458SIMMJEUwpqVnrPNvX-Bi7x_l9sl6ffKGYMn3ZHV2Py8-QAI3sx-Daz4BSkU3gA |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYQHMqFh9rCFlp8QL1l5WTteH1EULrAsqpQqnKz_MiqK6KAYFei_fXMOJtAeEgIcYsUj2WPZzwz9vgbQna5k-M48T4Ca8IjsMc-slyZSMhYGAgHesxhoHg6Sge_-fG5OJ-XA8K3MBU-RHPghpoR9mtUcDyQbms5WNcIfN6kxp0E49oFh3IJC3wjkP7BWYMlhYKnQvSlQDTAaLfTep7tqWWrlpDtt885ok_zKR_6ucFQHa6Sop5ilZ9y0Z1Nbdf9f4T--E48WCMrc4eW7lUSuE4W8vIjGZ7d3-BTTCMuaJ31Vd5QPPudlPSyzOk_UDQa6pTTq7poCC1gA6LTgLpewMJ_Itnhj2x_EM3rNkQO4fwiL7ywUhqe9_OEKQcRlmUmF954bkzMJXfcM9ezY8u4dWPRRxA2IWVqYQOKe5_JYglD2CSUWdVLGTfCestzlliJWEAmGUvv-17JDpH1Amk3xzTH0hqFfhDbAIM0MggrbiodGKRvOyRuKK8qXI9X0HwPMtAQmOsLzIuTQv8Z_dT7v07SY6kyPeiQnVpINGgrXsGYMr-c3UB3qQIHSb3cAgI4CHjSpEM2KqG6H57CV8-SwaRb4tY0QKTw9p9y8jcghiMkUj8FShGk6dUz1tnRAXx8eSPdDvkwyE6Heng0Otkiy9VFHOZObpPF6fUs_wr-3NR-C3p6B7ZVO5w |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dT9swELcmkNBe-BDbKLDhB8RbKie14_pxouvKxyqEOo03yx-JQK1CBa0E_PW7c5pA-JDQtLdI8Vn2-c53Z59_R8g-dzKPE-8jsCY8AnvsI8uViYSMhYFwoMMcBoq_hungNz--EBeL_Cd8C1PiQ9QHbqgZYb9GBZ_6vKnkYFwjcHmTCnYSbGsb_MllnjKFZRx65zWUFMqdCsGXAskAm93M6nm1p4apWkau373mh75Mp3zq5gY71V8j42qGZXrKuD2f2bZ7eAb--H9YsE5WF-4s_V7K3wb5kBWb5PT88f6eYhLxhFY5X8UtxZPfq4JeFxm9BzWjoUo5nVYlQ-gEth86C5jrE1j2T2TU_zE6HESLqg2RQzC_yAsvrJSGZ90sYcpBfGWZyYQ3nhsTc8kd98x1bG4Zty4XXYRgE1KmFrafuPOZLBUwhC1CmVWdlHEjrLc8Y4mViARkklx63_VKtois1ke7BaI5FtaY6CeRDTBII4Ow3qbSgUH6rkXimnJaonq8g-YgiEBNYG7GmBUnhf4z_KkPz07SY6lGetAie5WMaNBVvIAxRXY9v4XuUgXukXq7BYRvEO6kSYt8KWXqcXgK3zxLBpNuSFvdAHHCm3-Kq8uAF46ASN0UKEUQpnfPWI-OevCx_Y90e2TlrNfXp0fDkx3ysbyFw8TJXbI0u5lnX8GZm9lvQUv_AscQOks |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Respiratory+viral+infections+within+one+year+after+pediatric+lung+transplant&rft.jtitle=Transplant+infectious+disease&rft.au=Liu%2C+M.&rft.au=Worley%2C+S.&rft.au=Arrigain%2C+S.&rft.au=Aurora%2C+P.&rft.date=2009-08-01&rft.pub=Blackwell+Publishing+Inc&rft.issn=1398-2273&rft.eissn=1399-3062&rft.volume=11&rft.issue=4&rft.spage=304&rft.epage=312&rft_id=info:doi/10.1111%2Fj.1399-3062.2009.00397.x&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_CPK6J79T_H |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1398-2273&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1398-2273&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1398-2273&client=summon |